Information Provided By:
Fly News Breaks for December 18, 2019
Dec 18, 2019 | 07:26 EDT
Cowen analyst Doug Schenkel raised his price target on Illumina to $335 from $320 as he is increasingly confident in the outlook for a reacceleration of revenue growth to at least to low double digit levels in 2020. He based his analysis on the company's roughly 30 PopGen programs as well as the company's clinical customer base. Schenkel reiterated his Outperform rating on Illumina shares.
News For ILMN From the Last 2 Days
There are no results for your query ILMN